Intra-Cellular Therapies' CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar de ...
Researchers from the National University of Singapore (NUS) have pioneered a new catalytic transformation that converts ...
China’s share of the global drug development pipeline grew from 3% in 2013 to 28% in 2023, positioning China as the ...
The industry is on a strong growth trajectory, with experts predicting notable achievements over the next decade. Forecasts ...
Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...
Radiation Shield Technologies (RST) proudly announces that its groundbreaking anti-radiation fabric, Demron, has been chosen as a critical component in the design of the Mars Spacesuit. Highlighted in ...
Accuryn Medical, a company dedicated to addressing acute kidney injury through real-time renal assessment based on Kidney Disease Improving Global Outcomes (KDIGO) guidelines with the Accuryn ...
NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) ("NurExone" or the "Company") is pleased to announce the formation of a U.S.-based ...
TORONTO and HAIFA, Israel, Feb. 05, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF ... Exo-Top will be positioned to supply high-quality exosomes to other pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback